Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study.

Guillaume Ploussard,Frédéric Staerman,J. Pierrevelcin,S. Larue,Arnauld Villers,Adil Ouzzane,C. Bastide,Nicolas Gaschignard,François Buge,Christian Pfister,Romain Bonniol,Xavier Rébillard,Saad Fadli,Nicolas Mottet,Fabien Saint,Rodrigue Saad,J. B. Beauval,Morgan Rouprêt,François Audenet,M. Peyromaure,Nicolas Barry Delongchamps,S. Vincendeau,Tarek Fardoun,Jérôme Rigaud,Michel Soulie,Laurent Salomon

Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study.

2014

Purpose To assess oncologic outcomes after salvage radiotherapy (SRT) without androgen deprivation therapy (ADT) in patients with persistently detectable PSA after radical prostatectomy (RT).

Keywords:

Urology
Prostatectomy
Prostate-specific antigen
Combined Modality Therapy
Prostate cancer
Oncology
Androgen deprivation therapy
Radiation therapy
Retrospective cohort study
Internal medicine
Salvage therapy
Medicine
Nephrology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations